Increased release of immunoreactive dynorphin A 1-17 from the spinal cord after intrathecal treatment with endomorphin-2 in anesthetized rats

European Journal of Pharmacology

Volumn 504, Issue 3, 2004, Pages 177-183

  Leitermann, Randy J ^a   Terashvili, Maia ^a   Mizoguchi, Hirokazu ^a   Wu, Hsiang En ^a   Chen, Franklin ^a   Clithero, Andrew ^a   Tseng, Leon F ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Dynorphin A 1 17; Endomorphin 2; Spinal cord

Indexed keywords

3 METHOXYNALTREXONE; DYNORPHIN A; ENDOMORPHIN 1; ENDOMORPHIN 2; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; NALTREXONE DERIVATIVE; UNCLASSIFIED DRUG; URETHAN;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; IMMUNOREACTIVITY; MALE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; SPINAL CORD;

ANESTHESIA; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DYNORPHINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; INJECTIONS, SPINAL; MALE; NALOXONE; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; RATS; RECEPTORS, OPIOID, MU; SPINAL CORD;

EID: 8444252196     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.10.006     Document Type: Article

References (27)

1. G.P. Brown, K. Yang, M.A. King, G.C. Rossi, L. Leventhal, A. Chang, and G.W. Pasternak 3-Methoxynaltrexone, a selective heroin/morphine-6β- glucuronide antagonist FEBS Lett. 412 1997 35 38
2. J.M. Fujimoto, and J.J. Rady Intracerebroventricular physostigmine- induced analgesia: enhancement by naloxone, β-funaltrexamine and nor-binaltorphimine and antagonism by dynorphin A (1-17) J. Pharmacol. Exp. Ther. 251 1989 1045 1052
3. I.E. Goldberg, G.C. Rossi, S.R. Letchworth, J.P. Mathis, J. Ryan-Moro, L. Leventhal, W. Su, D. Emmel, E.A. Bolan, and G.W. Pasternak Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain J. Pharmacol. Exp. Ther. 286 1998 1007 1013
4. G. Horvath, M. Szikszay, C. Tomboly, and G. Benedek Antinociceptive effects of intrathecal endomorphin-1 and endomorphin-2 in rats Life Sci. 65 1999 2635 2641
5. 2-endomorphin-2, respectively, attenuate the antinociception induced by endomorphin-1 and endomorphin-2 given intrathecally in the mouse J. Pharmacol. Exp. Ther. 303 2002 874 879
6. T.M. Laughlin, A.A. Larson, and G.L. Wilcox Mechanisms of induction of persistent nociception by dynorphin J. Pharmacol. Exp. Ther. 299 2001 6 11
7. M.J. Millan The induction of pain: an integrative review Prog. Neurobiol. 57 1999 1 164
8. 35S] GTPγS binding in the mouse spinal cord Eur. J. Pharmacol. 351 1998 383 387
9. M. Narita, H. Mizoguchi, M. Narita, N.J. Dun, B.H. Hwang, T. Endoh, T. Suzuki, H. Nagase, T. Suzuki, and L.F. Tseng G protein activation by endomorphins in the mouse periaqueductal gray matter J. Biomed. Sci. 7 2000 221 225
10. M. Ohsawa, H. Mizoguchi, M. Narita, M. Chu, H. Nagase, and L.F. Tseng Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse J. Pharmacol. Exp. Ther. 294 2000 1106 1111
11. M. Ohsawa, H. Mizoguchi, M. Narita, H. Nagase, J.P. Kampine, and L.F. Tseng Differential antinociception induced by spinally administered endomorphin-1 and endomorphin-2 in the mouse J. Pharmacol. Exp. Ther. 298 2001 592 597
12. B. Przewlocka, J. Mika, D. Labuz, G. Toth, and R. Przewlocki Spinal analgesic action of endomorphins in acute, inflammatory, and neuropathic pain in rats Eur. J. Pharmacol. 367 1999 189 196
13. J.J. Rady, J.M. Fujimoto, and L.F. Tseng Dynorphins other than dynorphin A(1-17) lack spinal antianalgesic activity but do act on dynorphin A(1-17) J. Pharmacol. Exp. Ther. 259 1991 1073 1080
14. S. Sakurada, T. Hayashi, M. Yuhki, T. Fujimura, K. Murayama, A. Yonezawa, C. Sakurada, M. Takeshita, J.E. Zadina, A.J. Kastin, and T. Sakurada Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone Brain Res. 881 2000 1 8
15. S. Sakurada, T. Hayashi, M. Yuhki, T. Orito, J.E. Zadina, A.J. Kastin, T. Fujimura, K. Murayama, C. Sakurada, T. Sakurada, M. Narita, T. Suzuki, K. Tan-no, and L.F. Tseng Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse Eur. J. Pharmacol. 427 2001 203 210
16. P. Sanchez-Blanquez, I. DeAntonio, M. Rodriguez-Diaz, and J. Garzon Antisense oligodeoxynucleotide targeting distinct exons of the cloned μ-opioid receptor distinguish between endomorphin-1 and morphine supraspinal antinociception in mice Antisense Nucleic Acid Drug Dev. 9 1999 253 260
17. A.P. Smith, and N.M. Lee Pharmacology of dynorphin Ann. Rev. Pharmacol. Toxicol. 28 1988 123 140
18. M. Spetea, K. Monory, C. Tomboly, G. Toth, E. Tzavara, S. Benyhe, J. Hanoune, and A. Borsodi In vitro binding and signaling profile of the novel mu opioid receptor agonist endomorphin-2 in rat brain membranes Biochem. Biophys. Res. Commun. 250 1998 720 725
19. L.S. Stone, C.A. Fairbanks, T.M. Laughlin, H.O. Nguyen, T.M. Bushy, M.W. Wessendorf, and G.L. Wilcox Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2 NeuroReport 8 1997 3131 3135
20. H.H. Suh, and L.F. Tseng Intrathecal administration of thiorphan and bestatin enhances the antinociception and release of met-enkephalin induced by β-endorphin intraventricularly in anesthetized rats Neuropeptides 16 1990 91 96
21. H.H. Suh, K.A. Collins, and L.F. Tseng Intrathecal cholecystokinin octapeptide attenuates the antinociception and release of immunoreactive met-enkephalin induced by intraventricular β-endorphin in the rat Neuropeptides 21 1992 131 137
22. L.F. Tseng, and K.A. Collins Spinal involvement of both dynorphin A and met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse J. Pharmacol. Exp. Ther. 266 1993 1430 1438
23. L.F. Tseng Recent advances in the search of the μ-opioidergic system: the antinociceptive properties of endomorphin-1 and endomorphin-2 in the mouse Jpn. J. Pharmacol. 89 2002 216 220
24. H.-E. Wu, K.-C. Hung, H. Mizoguchi, H. Nagase, and L.F. Tseng Roles of endogenous opioid peptides in modulation of nocifensive response to formalin J. Pharmacol. Exp. Ther. 300 2002 647 654
25. H.-E. Wu, H. Mizoguchi, M. Terashvili, R.J. Leitermann, K.-C. Hung, J.M. Fujimoto, and L.F. Tseng Spinal pretreatment with antisense oligodeoxynucleotides against exon-1, -4, or -8 of μ-opioid receptor clone leads to differential loss of spinal endomorphin-1- and endomorphin-2-induced antinociception in the mouse J. Pharmacol. Exp. Ther. 303 2002 867 873
26. H.-E. Wu, H.-S. Sun, M. Darpolar, R.J. Leitermann, J.P. Kampine, and L.F. Tseng Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord J. Pharmacol. Exp. Ther. 307 2003 1135 1141
27. J.E. Zadina, L. Hackler, L.-J. Ge, and A.J. Kastin A potent and selective endogenous agonist for the μ-opioid receptor Nature 386 1997 499 502